Journal profile · Medicine-Immunology and Allergy
Revista Alergia Mexico
ISSN 0002-5151 · eISSN 2448-9190 · Sociedad Mexicana de Alergia e Inmunologia · Mexico
Revista Alergia Mexico: fully open access; APC about USD 300; median 42 days to acceptance (53 articles, last 24 months); 93 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Revista Alergia Mexico is published by Sociedad Mexicana de Alergia e Inmunologia. By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research and Allergic Rhinitis and Sensitization, together about 44.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
RAM publishes: Original research articles Systematic reviews Clinical guidelines and consensus documents Case reports Short communications The journal welcomes contributions on a wide range of topics in clinical immunology, allergy, and asthma, and is intended for researchers, clinicians, healthcare professionals, and specialists in related disciplines.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Immunology and Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine15.9%
- Food Allergy and Anaphylaxis ResearchMedicine15.3%
- Allergic Rhinitis and SensitizationMedicine13.4%
- Drug-Induced Adverse ReactionsMedicine10.3%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology5.4%
- Dermatology and Skin DiseasesMedicine4.2%
- Contact Dermatitis and AllergiesMedicine4.2%
- Occupational exposure and asthmaMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Allergy | Q4 | 218/234 | 7th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseSciELOPublisher website
Other: Latindex, EBSCO, Crossref, MedicLatina – Part of the EBSCO international database.
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.5LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.26LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 57OpenAlex ·
- 2-year mean citedness
- 0.29OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 758 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 42 | 246 |
| 2025 | 93 | 93 | 370 |
| 2024 | 59 | 59 | 439 |
| 2023 | 88 | 88 | 523 |
| 2022 | 18 | 18 | 314 |
| 2021 | 76 | 76 | 353 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
42 daysMedian, submission to acceptance · P25–P75 24 days – 89 days
- Acceptance to online
- median 125 days (53 articles)
- Submission to online
- median 194 days
- Sample
- 53 articles with submission and acceptance dates (117 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 300 | Yes | CC BY-NC | |
| OpenAlex | USD 300 | — | — | |
| LetPub | USD 300 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 2,500 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted11, with length limits
- brief reportBRIEF RESEARCH ARTICLE Presents new findings or a new interpretation of original diagnostic or therapeutic allergy /immunology researchfindings: new procedures,…main text ≤ 2,000 words · abstract ≤ 200 words
- brief reportsBrief reportsLength not stated
- case clinical reportsCase clinical reportsLength not stated
- editorialAll submitted manuscripts will be evaluated by the Editor-in-Chief, a Deputy Editor, or an Associate Editor, along with at least two peer reviewers. The editori…Length not stated
- letter to the editor1. Scope and Objective The "Letter to the Editor" section aims to provide a space for academic discussion and the exchange of opinions on relevant topics within…main text ≤ 800 words · references ≤ 5
- letters to the editorLetter to the Editor 1. Scope and Objective The "Letter to the Editor" section aims to provide a space for academic discussion and the exchange of opinions on r…main text ≤ 800 words · references ≤ 5
- original articleORIGINAL ARTICLE Scope and General Considerations All manuscripts submitted to Revista Alergia México must adhere to international editorial, methodological, an…main text ≤ 250 words
- original articlesOriginal articlesLength not stated
- research articleistical analysis is required. The Brief Research Article should be a maximum of 2000 words from introduction to discussion. The recommendations for thmain text ≤ 2,000 words
- review articleREVIEW ARTICLES Review articles submitted of Revista Alergia México must adhere to international editorial and methodological standards. Authors are encouraged …main text ≤ 250 words
- review articlesReview articlesLength not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship
Authors listed in order of contribution. Model summary
Authors Listed in order of contribution.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
ICMJE conflict of interest disclosure form required per author. Model summary
Each author must submit a conflict of interest statement using the ICMJE form. Clearly disclose any financial or non-financial conflicts of interest that may have influenced the development of the guideline.
Source ↗Publisher website ·- Publication ethics Ethical Considerations
Manuscripts must adhere to international editorial, methodological, and ethical standards. Model summary
Manuscripts must adhere to the ethical guidelines established by the Committee on Publication Ethics (COPE) (https://publicationethics.org). If the guideline involves human participants, authors must confirm compliance with the Declaration of Helsinki (https://www.wma.net/). If applicable, provide the approval number from the institutional research ethics committee.
Source ↗Publisher website ·- License & copyright Copyright and Editorial Costs
Copyright assignment is free of charge. Model summary
Articles published in supplements are subject to the same copyright policies as regular articles in Revista Alergia México. For details on editorial costs and fees, please refer to: https://revistaalergia.mx/ojs/index.php/ram/fees.
Source ↗Publisher website ·- Open access Open Access Policy
RAM is an open-access journal, meaning all published content is freely accessible without subscription fees. Authors are not charged for submission; however, article processing charges (APCs) may apply depending on the manuscript type and section.
Source ↗Publisher website ·- Peer review Evaluation and Peer Review
Double-blind peer review managed by the Editor-in-Chief or an Associate Editor; each article reviewed by at least two external experts. Model summary
All submitted guidelines undergo double-blind peer review by experts in the field. Reviewers evaluate the quality of evidence, clarity of recommendations, and overall relevance to clinical practice. Authors are expected to address reviewer comments promptly and thoroughly during the revision process.
Source ↗Publisher website ·- Preprints
Policy Guidelines correction and articles Distribution and Diffusion Model summary
Policy Guidelines correction and articles Distribution and Diffusion
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sociedad Mexicana de Alergia e Inmunologia
- Country or region
- Mexico
- Language
- Spanish
- ISSN
- 0002-5151
- Electronic ISSN
- 2448-9190
- Society / sponsor
- Mexican College of Asthma
- Latest issue on the website
- Volume 73, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Revista Alergia Mexico
How long does peer review take at Revista Alergia Mexico?
Based on the dates recorded on 53 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 42 days (interquartile range 24–89 days); authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Revista Alergia Mexico?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 3; Manuscript length: ≤ 2,500 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Revista Alergia Mexico?
According to LetPub and DOAJ records, Revista Alergia Mexico is indexed in Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, Embase and SciELO; that list has not been checked against each database.
Is Revista Alergia Mexico open access, and what is the APC?
Revista Alergia Mexico is a fully open-access journal. APC about USD 300.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .